Briacell Therapeutics Corp (BCTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $29.60M
Last updated: Nov 17, 2026 at 11:04 AM ET
Briacell Therapeutics Corp (BCTX) Earnings: Report Dates and Results
Briacell Therapeutics (BCTX) is expected to report earnings on Dec 10, 2026. In the quarter ended Jul 31, 2026, Briacell Therapeutics reported EPS of -$1.24. It beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Next Report
BCTX has an expected report date of Dec 10, 2026.
Earnings History
Of the 15 quarters below that had an estimate, BCTX beat 8 and missed 7. The widest gap in the table came in the quarter ended Oct 31, 2023, when EPS landed 300.00% above the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 | -$1.24 | N/A | N/A | N/A | N/A | -3200.0% | N/A | N/A | Oct 28, 2026 |
| Apr 30, 2026 | -$0.99 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 9, 2026 |
| Jan 31, 2026 | -$2.58 | -$4.84 | -$4.84 - -$4.84 | N/A | N/A | N/A | 1 | 0 up, 0 down | Mar 10, 2026 |
| Oct 31, 2025 | -$4.35 | -$3.28 | -$3.28 - -$3.28 | N/A | N/A | N/A | 1 | 0 up, 0 down | Dec 11, 2025 |
| Jul 31, 2025 | $0.04 | -$12.11 | -$12.11 - -$12.11 | +100.33% | Beat | N/A | 1 | 1 up, 0 down | Oct 27, 2025 |
| Apr 30, 2025 | -$16.40 | -$17.60 | N/A | +6.82% | Beat | -199.4% | N/A | 0 up, 0 down | Jun 16, 2025 |
| Jan 31, 2025 | -$2.33 | -$1.94 | N/A | -20.10% | Miss | N/A | N/A | 0 up, 0 down | Mar 12, 2025 |
| Oct 31, 2024 | -$33.00 | -$12.00 | N/A | -175.00% | Miss | -161.1% | N/A | 0 up, 0 down | Dec 16, 2024 |
| Jul 31, 2024 | -$0.07 | -$0.46 | N/A | +84.78% | Beat | N/A | 1 | 0 up, 0 down | Oct 23, 2024 |
| Apr 30, 2024 | $16.50 | -$82.50 | N/A | +120.00% | Beat | N/A | 1 | 0 up, 0 down | Jun 14, 2024 |
| Jan 31, 2024 | -$106.50 | -$30.00 | N/A | -255.00% | Miss | N/A | 1 | 0 up, 0 down | Mar 18, 2024 |
| Oct 31, 2023 | $54.00 | -$27.00 | N/A | +300.00% | Beat | N/A | 1 | 0 up, 0 down | Dec 14, 2023 |
| Jul 31, 2023 | -$0.15 | -$0.39 | N/A | +61.54% | Beat | N/A | N/A | N/A | Oct 25, 2023 |
| Apr 30, 2023 | -$48.00 | -$53.25 | N/A | +9.86% | Beat | N/A | N/A | N/A | Jun 14, 2023 |
| Jan 31, 2023 | -$115.50 | -$53.25 | N/A | -116.90% | Miss | N/A | N/A | 0 up, 0 down | Mar 15, 2023 |
| Oct 31, 2022 | -$10.50 | -$49.50 | N/A | +78.79% | Beat | N/A | N/A | 0 up, 0 down | Dec 14, 2022 |
| Jul 31, 2022 | -$1.02 | -$0.35 | -$0.35 - -$0.35 | -191.43% | Miss | N/A | 1 | 0 up, 0 down | Oct 27, 2022 |
| Apr 30, 2022 | -$48.00 | -$31.50 | N/A | -52.38% | Miss | -152.7% | 1 | 0 up, 0 down | Jun 13, 2022 |
| Jan 31, 2022 | -$36.00 | -$24.75 | N/A | -45.45% | Miss | N/A | 1 | 0 up, 0 down | Mar 15, 2022 |
| Oct 31, 2021 | -$0.16 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 14, 2021 |
| Apr 30, 2021 | $91.03 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 29, 2021 |
| Jan 31, 2021 | -$43.71 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2021 |
| Oct 31, 2020 | -$71.24 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Oct 31, 2020 |
| Jul 31, 2020 | -$105.72 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 31, 2020 |
| Apr 30, 2020 | -$105.79 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Apr 30, 2020 |
| Jan 31, 2020 | -$297.18 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Apr 30, 2020 |
| Oct 31, 2019 | -$1.82 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Oct 31, 2019 |
| Jul 31, 2019 | -$292.34 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 31, 2019 |
| Apr 30, 2019 | -$281.08 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Apr 30, 2019 |
| Jan 31, 2019 | -$328.34 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Apr 30, 2019 |
| Oct 31, 2018 | -$225.64 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Oct 31, 2018 |
| Jul 31, 2018 | -$465.55 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 31, 2018 |
| Apr 30, 2018 | -$464.88 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Apr 30, 2018 |
| Jan 31, 2018 | -$309.40 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jan 31, 2018 |
| Oct 31, 2017 | -$207.67 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Oct 31, 2017 |
| Jul 31, 2017 | -$382.27 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 31, 2017 |
| Apr 30, 2017 | -$387.91 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Apr 30, 2017 |
| Jan 31, 2017 | -$139.93 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Apr 30, 2017 |
| Oct 31, 2016 | -$163.55 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Oct 31, 2016 |
| Jul 31, 2016 | -$147.13 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 31, 2016 |
Annual EPS
EPS for the fiscal year ended Jul 31, 2026 was -$9.16, after -$51.69 the year before. It was -$865.95 for the year ended Jul 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Jul 31, 2026 | -$9.16 | N/A |
| Jul 31, 2025 | -$51.69 | N/A |
| Jul 31, 2024 | -$36.07 | N/A |
| Jul 31, 2023 | -$174.15 | N/A |
| Jul 31, 2022 | -$109.10 | N/A |
| Jul 31, 2020 | -$510.52 | N/A |
| Jul 31, 2019 | -$1,127.40 | N/A |
| Jul 31, 2018 | -$1,447.50 | N/A |
| Jul 31, 2017 | -$1,073.65 | N/A |
| Jul 31, 2016 | -$865.95 | N/A |
Frequently Asked Questions About BCTX
When is Briacell Therapeutics's next earnings date?
Briacell Therapeutics's next earnings report is expected for Dec 10, 2026.
How often does BCTX beat earnings estimates?
Briacell Therapeutics beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate, with an average surprise of +20.23%.
BCTX pages: Overview, Earnings, Financials, Competitors